Celastrol (), obtained from the roots of Hook F., is most likely to become an antitumor drug, but with severe cytotoxicity. Due to the lack of modifiable sites in the structure of celastrol, the structural diversity of the modified products obtained by synthesis in the previous studies is insufficient, which hinders the pace of its patent medicine. This study describes a method of microbial transformation to increase the modification site of celastrol and reduce its toxicity. The screening of endophytes from native plants was introduced in this context, which led to two novel stereoselective oxidation products such as -16-hydroxyl celastrol () and A-ring aromatized -16-hydroxyl celastrol (), along with a rare 7,9-octadecadienoic acid ester of celastrol (). Their structures were determined by extensive spectroscopic data analysis, especially 1D and 2D NMR. Compared with , compounds and exhibited similar antitumor activity in U251, A549, KG-1, and B16 cell lines. Compound had slightly decreased antitumor activity when compared with compound . Furthermore, compound - showed lower cytotoxicity against BV-2 (about 21-fold lower, : 92.82 μM, : 34.25 μM, and : 74.75 μM vs. celastrol: 4.35 μM), and also identical trends against H9c2 and PC12 cell lines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177160PMC
http://dx.doi.org/10.3389/fmicb.2022.810565DOI Listing

Publication Analysis

Top Keywords

celastrol
8
-16-hydroxyl celastrol
8
antitumor activity
8
cell lines
8
native endophytes
4
endophytes -mediated
4
-mediated biotransformation
4
biotransformation reduces
4
reduces toxicity
4
toxicity celastrol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!